Abiopharma

Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Erasca Reports Second Quarter 2026 Business Updates and Financial Results

Leonardo DRS Demonstrates Defeat of Group 1-2 Unmanned Aerial System Threats for Fielded SGT STOUT M-SHORAD

Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

NetApp Hosts First Quarter of Fiscal Year 2027 Financial Results Webcast

IZEA Reports Q2 2026 Revenue of $5.8 million, Advances Enterprise-Focused Growth Strategy

Presidio Production Company Announces Second Quarter 2026 Results

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity

VINCI COMPASS REPORTS SECOND QUARTER 2026 EARNINGS RESULTS AND ANNOUNCES THE ACQUISITION OF NAVIS REAL ESTATE PLATFORM

Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

City Ventures Sells Harbor Pointe in Santa Ana to Century Communities, Extending Long-Standing Partnerships with the City and Public Homebuilder

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)